Having verified that the peptides apidaecin 1b and Api88 - a designer peptide based on the native apidaecin 1b sequence - are highly active against Gram-negative bacteria , we studied their ability to modulate biological activities of human monocytes and mast cells ( MC ) , two important cell types of the human innate immune system .
